๐๐๐ฐ ๐๐๐๐ก๐ข๐ง๐ ๐๐๐ฅ๐ฉ๐ฌ ๐ญ๐จ ๐๐๐ฌ๐ญ๐จ๐ซ๐ ๐๐๐งโ๐ฌ ๐๐ข๐ฌ๐ข๐จ๐ง ๐จโโ๏ธ Surgeons at...
๐๐ญ๐๐ฆ ๐๐๐ฅ๐ฅ ๐๐ซ๐๐ง๐ฌ๐ฉ๐ฅ๐๐ง๐ญ ๐๐ก๐จ๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ๐ข๐ฌ๐ ๐ข๐ง ๐๐๐ฌ๐ญ๐จ๐ซ๐ข๐ง๐ ๐๐ข๐ฌ๐ข๐จ๐ง ๐๐จ๐ซ ๐๐จ๐ซ๐ง๐๐๐ฅ ๐๐๐ฆ๐๐ ๐ ๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ.
๐ A recent study published in The Lancet has shown promising results for stem cell therapy in treating patients with corneal damage. Researchers at Osaka University Hospital used corneal epithelial cell sheets derived from human induced pluripotent stem cells (iPSCs) to treat four patients with limbal stem-cell deficiency (LSCD).
๐ The results were encouraging: all patients showed improved vision and reduced corneal opacity after a year, with no significant adverse effects. This breakthrough paves the way for further research, including larger clinical trials to assess the potential of iPSCs as a treatment for LSCD.